Impact of weight loss on survival after chemoradiation for locally advanced head and neck Cancer: secondary results of a randomized phase III trial (SAKK 10/94)

[1]  D. Rietveld,et al.  Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy , 2013, British Journal of Cancer.

[2]  J. Roh,et al.  Prediction of Posttreament Significant Body Weight Loss and Its Correlation with Disease-Free Survival in Patients with Oral Squamous Cell Carcinomas , 2013, Nutrition and cancer.

[3]  T. Yen,et al.  Impact of pretreatment body mass index on patients with head-and-neck cancer treated with radiation. , 2012, International Journal of Radiation Oncology, Biology, Physics.

[4]  G. Jensen,et al.  Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition). , 2012, JPEN. Journal of parenteral and enteral nutrition.

[5]  J. Bernier,et al.  Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94). , 2010, International journal of radiation oncology, biology, physics.

[6]  Young Ho Yun,et al.  Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Cooper,et al.  Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: A secondary analysis of RTOG trial 90‐03 , 2006, Head & neck.

[8]  L. Zijp,et al.  Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma , 2004, Cancer.